Company News » Anti-Pembrolizumab Antibody(10E12C6)[Biotin], mAb, Mouse
Anti-Pembrolizumab Antibody(10E12C6)[Biotin], MAb, Mouse

Anti-Pembrolizumab antibody (10E12C6) (GenScript, A01845-40) binds with Pembrolizumab. While the antibody does not recognize the human IgG Fc fragment (data not shown).
Coating antigen: Pembrolizumab, 1 µg/ml.
Anti-Pembrolizumab antibody (GenScript, A01845-40) dilution start from 1,000 ng/ml,
EC50= 5.77 ng/ml

Anti-Pembrolizumab Antibody(10E12C6)[Biotin], MAb, Mouse

Anti-Pembrolizumab antibody (GenScript, A01845-40) blocks Pembrolizumab binding with Human PD-1 recombinant protein (Z03370, PD 1-Fc Chimera, Human).
Coating antigen: Pembrolizumab, 1 µg/ml.
PD 1-Fc-biotin final concentration: 20 ng/ml
Anti-Pembrolizumab antibody (GenScript, A01845-40) dilution start from 30 µg/ml,
IC50= 0.37 μg/ml

Anti-Pembrolizumab Antibody(10E12C6)[Biotin], mAb, Mouse

The product is specific for Pembrolizumab.
A01845
$139.00

Ask us a question
Overview
Specificity The product is specific for Pembrolizumab.
Host Species Mouse
Immunogen Pembrolizumab
Conjugate Biotin

Applications
Working concentrations for specific applications should be determined by the investigators. The appropriate concentrations may be affected by secondary antibody affinity, antigen concentration, the sensitivity of the method of detection, temperature, the length of the incubations, and other factors. The suitability of this antibody for applications other than those listed below has not been determined. The following concentration ranges are recommended starting points for this product.
Application Recommended Usage
ELISA 0.01-0.1 µg/ml
Competitive ELISA 10-50 µg/ml

Properties
Form Lyophilized
Storage Buffer Lyophilized with PBS, pH 7.4, containing 1% BSA and 0.02% sodium azide.
Reconstitution Reconstitute the lyophilized powder with deionized water (or equivalent) to an final concentration of 0.5 mg/mL.
Storage Instructions The lyophilized product remains stable up to 1 year at -20°C from date of receipt. Upon reconstitution, it can be stored for 2-3 weeks at 2-8°C or for up to 12 months at -20°C or below. Avoid repeated freeze and thaw cycles.
Purification Protein A affinity column
Isotype Mouse IgG1,κ
Clonality Monoclonal
Clone ID 10E12C6
Note GenScript can customize this product per customer's request including product size, buffer components, etc.

Examples
  • Anti-Pembrolizumab Antibody(10E12C6)[Biotin], MAb, Mouse
    • Anti-Pembrolizumab Antibody(10E12C6)[Biotin], MAb, Mouse

    Anti-Pembrolizumab antibody (10E12C6) (GenScript, A01845-40) binds with Pembrolizumab. While the antibody does not recognize the human IgG Fc fragment (data not shown).
    Coating antigen: Pembrolizumab, 1 µg/ml.
    Anti-Pembrolizumab antibody (GenScript, A01845-40) dilution start from 1,000 ng/ml,
    EC50= 5.77 ng/ml

  • Anti-Pembrolizumab Antibody(10E12C6)[Biotin], MAb, Mouse
    • Anti-Pembrolizumab Antibody(10E12C6)[Biotin], MAb, Mouse

    Anti-Pembrolizumab antibody (GenScript, A01845-40) blocks Pembrolizumab binding with Human PD-1 recombinant protein (Z03370, PD 1-Fc Chimera, Human).
    Coating antigen: Pembrolizumab, 1 µg/ml.
    PD 1-Fc-biotin final concentration: 20 ng/ml
    Anti-Pembrolizumab antibody (GenScript, A01845-40) dilution start from 30 µg/ml,
    IC50= 0.37 μg/ml


Background
Target Background Pembrolizumab (Keytruda) is a humanized monoclonal antibody that is approved by the U.S. Food and Drug Administration for the treatment of patients with unresectable or metastatic melanoma. Pembrolizumab binds to the human cell surface receptor PD-1 (Programmed Cell Death Protein 1) and blocks its interaction with PD-L1, resulting in the activation of T-cell-mediated immune responses against tumor cells.GenScript Anti-Pembrolizumab Antibody (10E12C6)[BIOTIN], mAb, Mouse is produced from a hybridoma resulting from the fusion of SP2/0 myeloma and B-lymphocytes obtained from a mouse immunized with Pembrolizumab.
Synonyms Mouse monoclonal to Keytruda

For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.